Dextromethorphan and Quinidine for Treating Agitation in Patients With Alzheimer Disease Dementia

被引：4
|
作者：
Ballard, Clive [1 ]
Sharp, Samantha [1 ]
Corbett, Anne [1 ]
机构：
[1] Kings Coll London, Wolfson Ctr Age Related Dis, London SE1 1UL, England
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2015年 / 314卷 / 12期
关键词：
CARE; AGGRESSION; PEOPLE;
D O I：
10.1001/jama.2015.10215
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：1233 / 1235
页数：3
相关论文
共 50 条
  • [1] Effect of Dextromethorphan-Quinidine on Agitation in Patients With Alzheimer Disease Dementia A Randomized Clinical Trial
    Cummings, Jeffrey L.
    Lyketsos, Constantine G.
    Peskind, Elaine R.
    Porsteinsson, Anton P.
    Mintzer, Jacobo E.
    Scharre, DouglasW.
    De La Gandara, Jose E.
    Agronin, Marc
    Davis, Charles S.
    Uyen Nguyen
    Shin, Paul
    Tariot, Pierre N.
    Siffert, Joao
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2015, 314 (12): : 1242 - 1254
  • [2] Deuterated dextromethorphan/quinidine for agitation in Alzheimer's disease
    Rita Khoury
    [J]. Neural Regeneration Research, 2022, (05) : 1013 - 1014
  • [3] Deuterated dextromethorphan/quinidine for agitation in Alzheimer's disease
    Khoury, Rita
    [J]. NEURAL REGENERATION RESEARCH, 2022, 17 (05) : 1013 - 1014
  • [4] Dextromethorphan-Quinidine for Agitation in Alzheimer Disease RESPONSE
    Newman, John C.
    Steinman, Michael A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (11): : 1166 - 1166
  • [5] Evidence for using dextromethorphan-quinidine for the treatment of agitation in dementia
    Tampi, Rajesh R.
    Joshi, Pallavi
    Marpuri, Padmapriya
    Tampi, Deena J.
    [J]. WORLD JOURNAL OF PSYCHIATRY, 2020, 10 (04): : 29 - 33
  • [6] Dextromethorphan-Quinidine for Agitation in Alzheimer Disease (vol 315, pg 1166, 2016)
    Cummings, J. L.
    Siffert, J.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 315 (15): : 1661 - 1661
  • [7] Safety, Tolerability, and Effectiveness of Dextromethorphan/Quinidine for Pseudobulbar Affect in Patients with Alzheimer's Disease/Dementia: PRISM-II
    Doody, Rachelle S.
    D'Amico, Stephen
    Cutler, Andrew J.
    Shin, Paul
    Ledon, Fred
    Yonan, Charles
    Siffert, Joao
    [J]. ANNALS OF NEUROLOGY, 2014, 76 : S99 - S100
  • [8] Dextromethorphan/Quinidine: Safety, Tolerability, and Effectiveness for Pseudobulbar Affect in Patients with Alzheimer's Disease/Dementia: PRISM-II-Dementia-Cohort Results
    Doody, R. S.
    D'Amico, S.
    Cutler, A. J.
    Shin, P.
    Ledon, E.
    Yonan, C.
    Siffert, J.
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2015, 63 : S34 - S34
  • [9] NPI Agitation/Aggression Domain Scores Demonstrate Clinically Meaningful Changes in a Phase 2 Study of Dextromethorphan/Quinidine (DM/Q) in Patients with Agitation in Alzheimer's Disease
    Dube, Sanjay
    Cummings, Jeffrey
    Cui, Harry
    Siffert, Joao
    [J]. NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S197 - S198
  • [10] Treating agitation and aggression in patients with Alzheimer's disease with escitalopram
    Veranic, Lea Zmuc
    Pregelj, Peter
    Jerin, Ales
    [J]. Psychogeriatrics, 2016, 16 (06) : 384 - 385
12345